SCHEMBL20144919

SCHEMBL20144919

CCOc1ccccc1C(=O)N1CCCC(Nc2ccc(Br)cn2)C1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR2 O43614 6/20 0.67
HCRTR1 O43613 5/20 0.67
CCNK O75909 1/20 0.47
CCNA2 P20248 1/20 0.47
CDK2 P24941 1/20 0.47
CDK7 P50613 1/20 0.47
CCNH P51946 1/20 0.47
MNAT1 P51948 1/20 0.47
CDK12 Q9NYV4 1/20 0.47
NPSR1 Q6W5P4 2/20 0.47
TSHR P16473 3/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
NOD2 Q9HC29 1/20 0.45
HTT P42858 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
LMNA P02545 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
KDM4E B2RXH2 1/20 0.44
KDM5A P29375 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20145234 1.00 HCRTR2 (0.67) HCRTR2HCRTR1CCNKCCNA2CDK2
SCHEMBL20144784 0.86 HCRTR2 (0.69) HCRTR2HCRTR1HTTLMNASMN1; SMN2
SCHEMBL18697642 0.86 HCRTR2 (0.69) HCRTR2HCRTR1HTTLMNASMN1; SMN2
SCHEMBL20144897 0.84 HCRTR2 (0.68) HCRTR2HCRTR1CCNKCCNA2CDK2
SCHEMBL16032435 0.80 HCRTR2 (1.00) HCRTR2HCRTR1TSHRMEN1KMT2A
SCHEMBL16032973 0.80 HCRTR2 (1.00) HCRTR2HCRTR1TSHRMEN1KMT2A
SCHEMBL16078132 0.80 HCRTR2 (1.00) HCRTR2HCRTR1TSHRMEN1KMT2A
SCHEMBL20144887 0.80 HCRTR2 (1.00) HCRTR2HCRTR1TSHRMEN1KMT2A
SCHEMBL20145172 0.80 HCRTR2 (0.46) HCRTR2HCRTR1NPSR1TSHRMEN1
SCHEMBL20145110 0.80 HCRTR2 (0.66) HCRTR2HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970207-B1 SUBSTITUTED PIPERIDINE COMPOUNDS AND THEIR USE AS OREXIN RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-05-16 EP disclosed